Rolf Koehler

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

Medicine, Hematology, Oncology +11

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Martin Schrappe, Maria Grazia Valsecchi, Claus R. Bartram et al. · Blood · 2011 · 438 citations · Full text

Life Sciences, Immunology, Immunotherapy +3

Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension

Rajiv D. Machado, Micheala A. Aldred, Victoria James et al. · Human Mutation · 2006 · 402 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 360 citations

Medicine, Hematology, Oncology +15

<i>IKZF1</i>^plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Martin Stanulla, Elif Dağdan, Markéta Žaliová et al. · Journal of Clinical Oncology · 2018 · 299 citations

Life Sciences, Genetics, Oncology +17